VIRPAX PHARMACEUTICALS INC (VRPX)

US9282512063 - Common Stock

0.33  +0.01 (+4.3%)

After market: 0.3538 +0.02 (+7.21%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
N/AN/AN/AN/AN/A
72.08%		N/A
46.30%		N/A
34.85%
EBITDA
YoY % growth
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
-2.626M-3.182M
-21.17%		-4.196M
-31.86%		-12.026M
-186.61%		-21.845M
-81.66%		-15.69M
28.18%		N/A
30.75%		N/A
25.00%		N/A
-11.74%		N/A
206.75%		N/A
364.92%		N/A
83.41%		N/A
50.78%
Operating Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
N/AN/AN/AN/AN/AN/A
-416.85%		N/A
64.13%		N/A
72.73%		N/A
30.00%		N/AN/AN/AN/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24
EPS
Q2Q % growth		-0.28
92.94%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth		N/A
EBIT
Q2Q % growth		-1.323M
71.76%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth		 -0.43
91.57%		-0.550.1221.93%
Q2 2024
Q2Q % growth		 -1.75 -1.56-0.19-12.14%
Q4 2023
Q2Q % growth		 -3.90
-749.67%		-2.75-1.15-41.61%
Q3 2023
Q2Q % growth		 -5.10
21.54%		-2.65-2.45-92.31%
Q3 2022
Q2Q % growth		 -6.50
-1,126.42%		-4.59-1.91-41.61%
Q2 2022
Q2Q % growth		 -5.00
-963.83%		-4.49-0.51-11.41%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 75.68% 0% 12.23%
RevenueN/A N/A N/A N/A